BridgeBio Pharma Inc (BBIO)
26.50
+0.28
(+1.09%)
USD |
NASDAQ |
Dec 20, 16:00
26.49
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma Total Assets (Quarterly): 664.98M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc | 219.48B |
| Alnylam Pharmaceuticals Inc | 4.205B |
| Cassava Sciences Inc | 223.75M |
| Regeneron Pharmaceuticals Inc | 37.44B |
| Vertex Pharmaceuticals Inc | 22.24B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.883B |
| Shareholders Equity (Quarterly) | -1.230B |
| Debt to Equity Ratio | -1.398 |
| Current Ratio | 3.193 |
| Net Debt Paydown Yield | -0.00% |